The Response Is Not the State in Lupus Nephritis: Why Treatment Categories Fail to Capture Disease Dynamics

This Evidence Note examines how treatment response in lupus nephritis is commonly interpreted as a stable outcome, and why this is misleading. Clinical categories such as “responder,” “insufficient response,” and “refractory disease” are used as if they reflect underlying disease states, assuming a direct and stable mapping between treatment and outcome. In practice, response is often transient, variable, and dependent on timing. Patients may show improvement while still having ongoing disease activity, and the same clinical data can support different treatment decisions depending on interpretation. This indicates that response does not define disease state, but reflects a moment within a dynamic trajectory. Drawing on clinical practice, treatment guidelines (KDIGO, ACR, EULAR), and known features of autoimmune disease behavior, this Evidence Note shows that response categories misclassify system dynamics. Improvement may occur within instability, and apparent success may precede deterioration. Within the URM framework, treatment response is interpreted as a signal within a dynamic system shaped by feedback, delay, variability, and trajectory. The key clinical shift is from asking whether a patient is responding to whether the system is stabilizing or still transitioning. This reframing has direct implications for clinical decision-making. Binary response categories risk masking heterogeneity, misinterpreting treatment effects, and guiding inappropriate escalation. Interpreting response over time, rather than as a fixed outcome, allows treatment to align with system behavior.